Literature DB >> 12452431

Rate-limiting steps in cytochrome P450 catalysis.

F Peter Guengerich.   

Abstract

Cytochrome P450 (P450) reactions are of interest because of their relevance to the oxidative metabolism of drugs, steroids, carcinogens, and other chemicals. One of the considerations about functional characterization is which steps of the catalytic cycle are rate-limiting. Detailed analysis indicates that several different steps can be rate-limiting with individual P450 reactions. N-Dealkylation of para-substituted N,N-dimethylanilines is a function of the electron withdrawing/donating properties of the substituent and the oxidation-reduction potential of the substrate, supporting a role in rate-limiting electron transfer from substrate to the high valent P450. In the oxidations of ethanol and acetaldehyde by human P450 2E1, a step following product formation must be the slow step (but not product release per se). Several oxidations catalyzed by human P450s 1A2 and 2D6 show slow C-H bond breaking, and apparent high-valent iron complexes accumulate in the reaction steady-state. Kinetic simulations were used to test the suitability of potential schemes and to probe the effects of changes in individual reaction steps.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452431     DOI: 10.1515/BC.2002.175

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  18 in total

1.  Catalytic mechanism of cytochrome P450 for 5'-hydroxylation of nicotine: fundamental reaction pathways and stereoselectivity.

Authors:  Dongmei Li; Xiaoqin Huang; Keli Han; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2011-04-22       Impact factor: 15.419

2.  Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.

Authors:  Kaila M Pianalto; Jessica H Hartman; Gunnar Boysen; Grover P Miller
Journal:  Toxicol Lett       Date:  2013-09-08       Impact factor: 4.372

3.  Thermal inactivation of the reductase domain of cytochrome P450 BM3.

Authors:  Arvind P Jamakhandi; Brandon C Jeffus; Vandana R Dass; Grover P Miller
Journal:  Arch Biochem Biophys       Date:  2005-07-15       Impact factor: 4.013

4.  CYP2C9-CYP3A4 protein-protein interactions: role of the hydrophobic N terminus.

Authors:  Murali Subramanian; Harrison Tam; Helen Zheng; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2010-03-09       Impact factor: 3.922

5.  Mechanism of the P450-Catalyzed Oxidative Cyclization in the Biosynthesis of Griseofulvin.

Authors:  Jessica M Grandner; Ralph A Cacho; Yi Tang; K N Houk
Journal:  ACS Catal       Date:  2016-05-31       Impact factor: 13.084

6.  Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates.

Authors:  Jessica H Hartman; H Cass Martin; Andres A Caro; Amy R Pearce; Grover P Miller
Journal:  Toxicology       Date:  2015-10-14       Impact factor: 4.221

7.  Regulation of cytochrome b5 expression by miR-223 in human liver: effects on cytochrome P450 activities.

Authors:  Kei Takahashi; Yuki Oda; Yasuyuki Toyoda; Tatsuki Fukami; Tsuyoshi Yokoi; Miki Nakajima
Journal:  Pharm Res       Date:  2014-03       Impact factor: 4.200

8.  Cooperative effects for CYP2E1 differ between styrene and its metabolites.

Authors:  Jessica H Hartman; Gunnar Boysen; Grover P Miller
Journal:  Xenobiotica       Date:  2013-01-18       Impact factor: 1.908

9.  Cytochrome P450 reductase: a harbinger of diffusible reduced oxygen species.

Authors:  Kelath Murali Manoj; Sudeep Kumar Gade; Lazar Mathew
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

10.  Predicting CYP2C19 catalytic parameters for enantioselective oxidations using artificial neural networks and a chirality code.

Authors:  Jessica H Hartman; Steven D Cothren; Sun-Ha Park; Chul-Ho Yun; Jerry A Darsey; Grover P Miller
Journal:  Bioorg Med Chem       Date:  2013-04-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.